These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 992534)

  • 21. [The incidence of serum anti-HBc and anti-HBs and tissue HBcAg in patients with HBsAg-negative hepatopathy].
    Giuliani-Piccari G; Orlandi G; Roccuzzo S; D'Imperio N; Formica G; Piemontese A; Sarti F
    G Clin Med; 1981 Feb; 62(2):94-102. PubMed ID: 7239059
    [No Abstract]   [Full Text] [Related]  

  • 22. [Australia-(hepatitis-B-) antigen. Properties and clinical significance].
    Sauerbruch T
    Med Klin; 1974 Dec; 69(51-52):2106-15. PubMed ID: 4216755
    [No Abstract]   [Full Text] [Related]  

  • 23. [Frequency of antigen associated to hepatitis due to virus B (HBAg) and of antibody (HBAc) in healthy subjects and during of course of acute and chronic hepatitis. Radioimmunologic study].
    Realdi G; Tremolada F; Alberti A; Rigoli A; Diodati G; Visconti M
    Quad Sclavo Diagn; 1975 Jun; 11(2):419-30. PubMed ID: 1223946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis].
    Marinucci G; Muglia M; Di Giacomo C; Petrucci L; Mancini R; Costa F; Bachetoni A
    Quad Sclavo Diagn; 1981 Mar; 17(1):81-5. PubMed ID: 7313073
    [No Abstract]   [Full Text] [Related]  

  • 25. [Significance of Australia antigen in the differential diagnosis and prognosis of hepatitis].
    Baenkler HW
    Fortschr Med; 1977 Mar; 95(9):577-9. PubMed ID: 844784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Importance of hepatitis B antigens and hepatitis B antibodies from the clinical point of view].
    Renger F; Frank KH; Reimann W; Tschöpel L; Müller C
    Dtsch Z Verdau Stoffwechselkr; 1976; 36(3-4):121-2. PubMed ID: 66125
    [No Abstract]   [Full Text] [Related]  

  • 27. [Australia-SH antigen isolation in patients with liver disease].
    Kaboth U; Schober A; Arndt HJ; Vido I; Creutzfeldt W
    Bibl Haematol; 1971; 37():245-50. PubMed ID: 5138911
    [No Abstract]   [Full Text] [Related]  

  • 28. The presence of Australia antigen in the serum of acute viral hepatitis contacts: the incidence of Australia antigen and homologous antibodies in an epidemic focus of acute viral hepatitis.
    Brănescu L; Moisa I; Babeş VT
    Rev Roum Inframicrobiol; 1971; 8(4):209-12. PubMed ID: 5005037
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatocellular carcinoma and hepatitis B virus markers in Europe.
    Vargas V; Pedreira JD; Vilaseca J; Ruiz J; Esteban R; Hernandez JM; Guardia J; Bacardi R
    Lancet; 1979 Mar; 1(8118):721-2. PubMed ID: 85956
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hepatitis B vaccines. An evaluation of human plasma extracted vaccines].
    Prince AM; Vnek J
    Fortschr Med; 1982 Oct; 100(40):1839-43. PubMed ID: 6293948
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis B core antigen and antibody.
    Hoofnagle JH; Gerety RJ; Barker LF
    Dev Biol Stand; 1975; 30():175-85. PubMed ID: 1204955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Australia antigen in various liver diseases (except acute hepatitis). 3].
    Migneco G; Mansueto S; Tripi S
    G Mal Infett Parassit; 1971 Dec; 23(12):1125-6. PubMed ID: 5151318
    [No Abstract]   [Full Text] [Related]  

  • 33. [Detection of anti-HBc carrier state in blood donors with the Corab kit. Its relationship to anti-HBbrno and hepatitis B virus carrier state].
    Pintera J; Krácmar C
    Cas Lek Cesk; 1980 Sep; 119(36-37):997-1002. PubMed ID: 7438178
    [No Abstract]   [Full Text] [Related]  

  • 34. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
    Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
    Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B viral infection: part I. Clinical features.
    Dzik WH; Alter HJ
    Am Fam Physician; 1982 Aug; 26(2):119-26. PubMed ID: 6285684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of a direct antiBody against nuclear antigen in hepatitis B using indirect immunofluorescence].
    Monacelli M; De Bac C; Turbessi G
    Boll Soc Ital Biol Sper; 1975 Nov; 51(21):1537-40. PubMed ID: 782488
    [No Abstract]   [Full Text] [Related]  

  • 37. [Incidence of HBAg in various liver diseases (comparison between radioimmunologic methods and methods of passive hemagglutination)].
    Claar GM; Alvaro MC; Ascione A; De Bellis G; Sodano S; Varone GL
    Quad Sclavo Diagn; 1975 Jun; 11(2):561-6. PubMed ID: 1223959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Incidence of HBe antigens and antibodies in the serum of patients treated at the Infectious Disease Clinic and Hepatological Outpatient Clinic in Lublin].
    Modrzewska R; Rzeszowska G; Pieciński Z; Radomińska I
    Pol Tyg Lek; 1981 Sep; 36(38):1463-5. PubMed ID: 7329861
    [No Abstract]   [Full Text] [Related]  

  • 39. [Infection due to hepatitis B virus and host immune response].
    Realdi G; Bortolotti F; Alberti A; Fattovich G; Ongaro G
    Boll Ist Sieroter Milan; 1976 Sep; 55(4):323-34. PubMed ID: 1016586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of hepatitis-B antigen carriers in non-parenteral transmission of the hepatitis-B virus.
    Heathcote J; Gateau P; Sherlock S
    Lancet; 1974 Aug; 2(7877):370-1. PubMed ID: 4137173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.